Quarterly Result30 Oct 2026, 04:51 pm
Amerise Biosciences Declares Un-audited Results for Q2 FY27
AI Summary
Amerise Biosciences Limited announced that its Board of Directors, in a meeting held on October 30, 2026, approved the un-audited financial results for the quarter and half-year ended September 30, 2026. The board meeting commenced at 3:45 PM and concluded at 4:15 PM. The statutory auditors have carried out a limited review of these financial results. The company operates in a single segment.
Key Highlights
- Board approved un-audited financial results.
- Results for quarter and half-year ended September 30, 2026.
- Limited review conducted by statutory auditors.
- Company operates in a single business segment.
Price Impact
More from AMERISE